NH drug info case begins

Share this article:
IMS Health and Verispan will seek to protect the right to market prescription data from pharmacies in a case beginning this week. The research firms are bringing the case in US District Court in New Hampshire in the hope of striking down a law that took effect in the state last August, the Prescription Privacy Protection Act. The case’s outcome could set a precedent for states such as Nebraska, Nevada and Missouri, which have introduced copycat bills. New York is expected to do so this year. By banning the commercial use of prescription audit data, the act is designed to stop pharmaceutical sales people from influencing physicians’ medical decisions as well as help cut healthcare costs by leading to prescribing of less expensive drugs, say proponents. Under an exemption in the law, organizations can use the information as long as they do not profit from it. IMS and Verispan argue that the act restricts the flow of essential prescriber information and that it violates First Amendment free-speech protections. New Hampshire Rep. Cindy Rosenwald introduced the bill after her husband, a cardiologist, complained of being targeted by a sales rep.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Star Group merges with Vox Medica, Calcium NYC

Star Group merges with Vox Medica, Calcium NYC

The newly formed group will be known as Calcium with Steve Michaelson, formerly of Rosetta Wishbone, at the helm.

Survey finds pay doesn't make doctors happy

Survey finds pay doesn't make doctors happy

Medscape's survey of over 24,000 physicians found that a paycheck is not necessarily linked to a physician's professional satisfaction.

CDC sees declines in some diabetes complications

CDC sees declines in some diabetes complications

Centers for Disease Control data shows that diabetes complications including heart attack and amputation fell in the twenty years between 1990 and 2010. The bad news: the number of diagnosed ...